Does DABIGATRAN ETEXILATE Cause Interstitial lung disease? 86 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Interstitial lung disease have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.2% of all adverse event reports for DABIGATRAN ETEXILATE.
86
Reports of Interstitial lung disease with DABIGATRAN ETEXILATE
0.2%
of all DABIGATRAN ETEXILATE reports
29
Deaths
53
Hospitalizations
How Dangerous Is Interstitial lung disease From DABIGATRAN ETEXILATE?
Of the 86 reports, 29 (33.7%) resulted in death, 53 (61.6%) required hospitalization, and 6 (7.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Interstitial lung disease Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB